Compare Globus Medical Inc. Class A Common Stock (GMED) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Zoom Video Communications, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Zoom Video Communications, Inc. trades at $93.87 (market cap $28.64B). The key difference: Zoom Video Communications, Inc. is far larger — about 2.8× Globus Medical Inc. Class A Common Stock's market cap, and Zoom Video Communications, Inc. is more actively traded (2,595,677 versus 1,108,124). Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Zoom Video Communications, Inc. for 92 Days on average.
| GMED | ZM | |
|---|---|---|
Market Cap | $10.25B | $28.64B |
Volume | 1,108,124 | 2,595,677 |
Sector | Health | Technology |
52-Week High | $96.82 | $111.88 |
52-Week Low | $58.33 | $72.72 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $9.76B | $21.45B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Zoom Communications (ZM) trades at $94.47, down 3.54% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $118.08. The company reported strong profitability with a net income margin of 65.19% in 2026 and is advancing its AI-powered revenue OS, positioning for growth amid recent earnings beats.
The stock presents a compelling opportunity given its attractive valuation (P/E of 9.11) and robust fundamentals, though risks include reliance on international sales and competitive pressures in the communication software sector. Upside potential exists if the company executes on its AI initiatives and maintains earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
